All Stories

  1. The Role of Microglia during West Nile Virus Infection of the Central Nervous System
  2. Impact of FilmArray meningitis encephalitis panel on HSV testing and empiric acyclovir use in children beyond the neonatal period
  3. Review of neurological complications of COVID19/SARSCoV2
  4. 1889. Clinical Features Distinguishing Enterovirus A71 and Enterovirus D68-Associated Acute Flaccid Myelitis in Colorado, 2013–2018
  5. 652. Impact of FilmArray Meningitis Encephalitis Panel on HSV Testing and Acyclovir Use in Children Beyond the Neonatal Period
  6. Understanding Enterovirus D68-Induced Neurologic Disease: A Basic Science Review
  7. Enterovirus D68–Associated Acute Flaccid Myelitis
  8. Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody
  9. EV-D68 strains from the 2014 epidemic have acquired the capacity to infect human neuronal cells
  10. Acute viral encephalitis
  11. Enterovirus D68 can cause acute flaccid myelitis
  12. Microglial cells protect against viruses causing Japanese and West Nile encephalitis
  13. Contemporary circulating enterovirus D68 strains show differential viral entry and replication in human neuronal cells
  14. A new test for diagnosis of cases of chronic meningitis
  15. Encephalitis in US Children
  16. Infections and Inflammatory Disorders
  17. Evaluating Treatment Efficacy in a Mouse Model of Enterovirus D68–Associated Paralytic Myelitis
  18. Outcomes of Colorado children with acute flaccid myelitis at 1 year
  19. A mouse model of a new polio-like paralytic illness associated with enterovirus infection
  20. Hepatitis E Virus and Guillain-Barré Syndrome
  21. In Memoriam: H. Richard Tyler, MD (1927-2016)
  22. H. Richard Tyler, MD (1927–2016)
  23. Rationale for the Evaluation of Fluoxetine in the Treatment of Enterovirus D68-Associated Acute Flaccid Myelitis
  24. Fingolimod and Risk of Varicella-Zoster Virus Infection
  25. Activation of Intrinsic Immune Responses and Microglial Phagocytosis in an Ex Vivo Spinal Cord Slice Culture Model of West Nile Virus Infection
  26. Current developments in understanding of West Nile virus central nervous system disease
  27. West Nile and St. Louis encephalitis viruses
  28. Death Receptor-Mediated Apoptotic Signaling Is Activated in the Brain following Infection with West Nile Virus in the Absence of a Peripheral Immune Response
  29. Elevated CSF Cytokines in the Jarisch-Herxheimer Reaction of General Paresis
  30. PML therapy: “It's Déjà vu all over again”
  31. Daxx Upregulation within the Cytoplasm of Reovirus-Infected Cells Is Mediated by Interferon and Contributes to Apoptosis
  32. Slice Culture Modeling of Central Nervous System (CNS) Viral Infection
  33. West Nile virus growth is independent of autophagy activation
  34. Activation of Innate Immune Responses in the Central Nervous System during Reovirus Myelitis
  35. Signal Transducer and Activator of Transcription-5 Mediates Neuronal Apoptosis Induced by Inhibition of Rac GTPase Activity
  36. Comment: PML and adhesion molecule therapy
  37. Neuro-Intensive Care of Patients with Acute CNS Infections
  38. Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis
  39. Issues and Updates in Emerging Neurologic Viral Infections
  40. Type I interferon signaling limits reoviral tropism within the brain and prevents lethal systemic infection
  41. A brain slice culture model of viral encephalitis reveals an innate CNS cytokine response profile and the therapeutic potential of caspase inhibition
  42. The Proapoptotic Bcl-2 Protein Bax Plays an Important Role in the Pathogenesis of Reovirus Encephalitis
  43. ASK THE EXPERTS
  44. Progressive multifocal leukoencephalopathy: Can we reduce risk in patients receiving biological immunomodulatory therapies?
  45. Caspase-3 activation is required for reovirus-induced encephalitisin vivo
  46. Neurology Today Associate Editor Kenneth L. Tyler, MD, Comments:
  47. Gene expression in the brain during reovirus encephalitis
  48. Infections and Inflammatory Disorders
  49. Disrupted Glutamate Transporter Expression in the Spinal Cord With Acute Flaccid Paralysis Caused by West Nile Virus Infection
  50. Emerging Viral Infections of the Central Nervous System
  51. Cardiac Cell-specific Apoptotic and Cytokine Responses to Reovirus Infection: Determinants of Myocarditic Phenotype
  52. Emerging Viral Infections of the Central Nervous System
  53. Progressive Multifocal Leukoencephalopathy, Efalizumab, and Immunosuppression
  54. Impact of rituximab-associated B-cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients
  55. Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis
  56. Fas-Mediated Apoptotic Signaling in the Mouse Brain following Reovirus Infection
  57. Reovirus Activates Transforming Growth Factor β and Bone Morphogenetic Protein Signaling Pathways in the Central Nervous System That Contribute to Neuronal Survival following Infection
  58. Apoptosis in animal models of virus-induced disease
  59. 53. Nerve conduction study and electromyography aids in early identification of west nile infection in the immunosuppressed
  60. Prednisolone—but not antiviral drugs—improves outcome in patients with Bell's palsy
  61. Chapter 28 A history of bacterial meningitis
  62. Neurological infections: advances in therapy, outcome, and prediction
  63. Preface
  64. The 50th birthday of progressive multifocal leukoencephalopathy: New insights into pathogenesis
  65. North American Encephalitic Arboviruses
  66. Prions' Travels—Feces and Transmission of Prion Diseases
  67. Reduplicative paramnesia in Morvan's syndrome
  68. Experimental Reovirus-Induced Acute Flaccid Paralysis and Spinal Motor Neuron Cell Death
  69. Persistent Neurobehavioral Signs and Symptoms Following West Nile Fever
  70. Infections of the Nervous System
  71. West Nile virus and the central nervous system
  72. Reoviruses: General Features
  73. Bell's Palsy — Is Glucocorticoid Treatment Enough?
  74. Glutathione Binding to the Bcl-2 Homology-3 Domain Groove
  75. Novel Strategy for Treatment of Viral Central Nervous System Infection by Using a Cell-Permeating Inhibitor of c-Jun N-Terminal Kinase
  76. Colorado Surveillance Program for Chronic Wasting Disease Transmission to Humans
  77. An 85-year-old man with chronic lymphocytic leukemia and altered mental status
  78. Herpesvirus infections of the nervous system
  79. JAK-STAT signaling pathways are activated in the brain following reovirus infection
  80. Down-regulation of cFLIP following reovirus infection sensitizes human ovarian cancer cells to TRAIL-induced apoptosis
  81. West Nile virus neuroinvasive disease
  82. West Nile virus meningoencephalitis
  83. CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis
  84. Genes Induced by Reovirus Infection Have a Distinct Modular Cis- Regulatory Architecture
  85. Progressive Multifocal Leukoencephalopathy, Natalizumab, and Multiple Sclerosis
  86. Reovirus infection of the CNS enhances iNOS expression in areas of virus-induced injury
  87. Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
  88. Inhibition of Rac GTPase triggers a c-Jun- and Bim-dependent mitochondrial apoptotic cascade in cerebellar granule neurons
  89. Inhibition of NF-κ B activity and cFLIP expression contribute to viral-induced apoptosis
  90. Minocycline delays disease onset and mortality in reovirus encephalitis
  91. Mechanisms of Reovirus-Induced Cell Death and Tissue Injury: Role of Apoptosis and Virus-Induced Perturbation of Host-Cell Signaling and Transcription Factor Activation
  92. Nonstructural Protein  1s Is a Determinant of Reovirus Virulence and Influences the Kinetics and Severity of Apoptosis Induction in the Heart and Central Nervous System
  93. Dual Infections of the Central Nervous System with Epstein‐Barr Virus
  94. Herpesvirus Infection and Peripheral Neuropathy
  95. Molecular diagnosis of CNS viral infections
  96. JNK Regulates the Release of Proapoptotic Mitochondrial Factors in Reovirus-Infected Cells
  97. Caspase Inhibition Protects against Reovirus-Induced Myocardial Injury In Vitro and In Vivo
  98. Molecular Methods for Diagnosis of Viral Encephalitis
  99. COMMENTARY: Gibbs CJ Jr, Amyx HL, Bacote A, Masters CL, Gajdusek DC. Oral Transmission of Kuru, Creutzfeldt‐Jakob Disease, and Scrapie to Nonhuman Primates. J Infect Dis 1980; 142:205–208.
  100. Naturally Acquired West Nile Virus Encephalomyelitis in Transplant Recipients
  101. West Nile Virus Infection in the United States
  102. Novel Nuclear Herniations Induced by Nuclear Localization of a Viral Protein
  103. Regional Differences in Viral Growth and Central Nervous System Injury Correlate with Apoptosis
  104. Does Toll-like receptor 3 play a biological role in virus infections?
  105. Isolation and Molecular Characterization of a Novel Type 3 Reovirus from a Child with Meningitis
  106. Origins and early descriptions of ?Duchenne muscular dystrophy?
  107. Reovirus-Induced Alteration in Expression of Apoptosis and DNA Repair Genes with Potential Roles in Viral Pathogenesis
  108. MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblasts
  109. Recurrent Dermatomal Vesicular Skin Lesions
  110. Human Herpesvirus 6 and Multiple Sclerosis: The Continuing Conundrum
  111. Two Distinct Phases of Virus-induced Nuclear Factor κB Regulation Enhance Tumor Necrosis Factor-related Apoptosis-inducing Ligand-mediated Apoptosis in Virus-infected Cells
  112. Creutzfeldt–Jakob Disease
  113. Goltz, Friedrich Leopold
  114. Gowers, William Richard
  115. Hitzig, Eduard
  116. Mitchell, Silas Weir
  117. Acute Viral Infections of the Central Nervous System
  118. Central Nervous System Apoptosis in Human Herpes Simplex Virus and Cytomegalovirus Encephalitis
  119. Progressive Multifocal Leukoencephalopathy and Apoptosis of Infected Oligodendrocytes in the Central Nervous System of Patients With and Without AIDS
  120. Reovirus-Induced Apoptosis Requires Mitochondrial Release of Smac/DIABLO and Involves Reduction of Cellular Inhibitor of Apoptosis Protein Levels
  121. Type 3 Reovirus Neuroinvasion after Intramuscular Inoculation: Viral Genetic Determinants of Lethality and Spinal Cord Infection
  122. Quantitative CSF PCR in Epstein-Barr virus infections of the central nervous system
  123. Reovirus-induced apoptosis requires both death receptor- and mitochondrial-mediated caspase-dependent pathways of cell death
  124. Reovirus-Induced Alterations in Gene Expression Related to Cell Cycle Regulation
  125. Reovirus-induced neuronal apoptosis is mediated by caspase 3 and is associated with the activation of death receptors
  126. TRAIL and inhibitors of apoptosis are opposing determinants for NF-κB-dependent, genotoxin-induced apoptosis of cancer cells
  127. Reovirus Infection Activates JNK and the JNK-Dependent Transcription Factor c-Jun
  128. Reoviruses and the host cell
  129. Caspase 8-dependent sensitization of cancer cells to TRAIL-induced apoptosis following reovirus-infection
  130. Polymerase Chain Reaction as a Diagnostic Adjunct in Herpesvirus Infections of the Nervous System
  131. Reovirus-Induced ς1s-Dependent G2/M Phase Cell Cycle Arrest Is Associated with Inhibition of p34cdc2
  132. West Nile Virus Encephalitis in America
  133. Calpain Inhibition Protects against Virus-Induced Apoptotic Myocardial Injury
  134. Reovirus-Induced G2/M Cell Cycle Arrest Requires ς1s and Occurs in the Absence of Apoptosis
  135. Reovirus-Induced Apoptosis Is Mediated by TRAIL
  136. MEK kinase 1 gene disruption alters cell migration and c-Jun NH 2 -terminal kinase regulation but does not cause a measurable defect in NF-κB activation
  137. Reovirus-Induced Apoptosis Requires Activation of Transcription Factor NF-κB
  138. Polymerase Chain Reaction in the Diagnosis and Management of Central Nervous System Infections
  139. Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy
  140. Viral infections of the nervous system, 2nd ed
  141. PATHOGENESIS | Animal Viruses
  142. REOVIRUSES (REOVIRIDAE) | General Features
  143. A Herpes Simplex Virus DNA Polymerase Mutation That Specifically Attenuates Neurovirulence in Mice
  144. Profound cerebrospinal fluid pleocytosis and Froin's Syndrome secondary to widespread necrotizing vasculitis in an HIV-positive patient with varicella zoster virus encephalomyelitis
  145. Serious Methodological Failures Concerning Presence of HSV DNA in Surgical Tissue From Human Epileptic Seizure Foci Detected by PCR
  146. Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts
  147. Eradication of Persistent Reovirus Infection from a B-Cell Hybridoma
  148. Acute arcuate fiber demyelinating encephalopathy following epstein-barr virus infection
  149. Polymerase chain reaction and the diagnosis of viral central nervous system diseases
  150. Human Transmissible Neurodegenerative Diseases (Prion Diseases)
  151. William G. Spiler
  152. Pathogenesis of reovirus infections of the central nervous system
  153. Host and viral factors that influence viral neurotropism II. Viral genes, host genes, site of entry and route of spread of virus
  154. Host and viral factors that influence viral neurotropism I. Viral cell attachment proteins and target cell receptors
  155. Molecular pathogenesis of neurotropic viral infections
  156. Diagnosis and Management of Acute Viral Encephalitis
  157. Hughlings Jackson: The Early Development of His Ideas on Epilepsy
  158. Cerebral amyloid angiopathy with multiple intracerebral hemorrhages